Search clinical trials for: AI-driven Vaccine Communicator

Total 120 results

The Hong Kong Polytechnic University

Not yet recruiting

The Impact of a Web-based Psychoeducation Programme With a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy

COVID-19 | Vaccine Hesitancy
Turku University Hospital

Unknown

Safety and Reliability of Artificial Intelligence Driven Symptom Assessment in Children and Adolescentes

Artificial Intelligence | Triage
University of California, San Diego

Completed

An Artificial Intelligence-Assisted Digital Health Lifestyle Intervention for Adults With Hypertension

Hypertension

United States
Duke University

Completed

DHL Survey on Generative AI for MyChart Messaging

Communication

United States
Southcentral Foundation
University of Colorado, Denver; University of Washington; Washington State University and other collaborators

Completed

Palliative Care Communication With Alaska Native and American Indian People (PALL)

Advance Care Planning

United States
Novartis Vaccines

Completed

Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions

Seasonal Influenza | Vaccine

Germany
Ology Bioservices

Completed

Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004

Influenza

Poland
Jiangsu Province Centers for Disease Control and...
Shandong Hengye Biotech Co., Ltd.

Completed

A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants

Encephalitis

China
Novartis Vaccines
Novartis Vaccines and Diagnostics S.r.l.

Completed

Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly

Influenza

Poland
Ology Bioservices

Completed

Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005

Influenza

Austria, Germany
Ology Bioservices

Completed

Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)

Influenza

Germany, Austria
Enimmune Corporation

Completed

A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric Subjects

Enterovirus Infections

Taiwan
National University of Singapore

Recruiting

Use of Artificial Intelligence Cardiac Ultrasound Technology in Teaching Point of Care Cardiac Ultrasound

Cardiac

Singapore
Novartis Vaccines

Completed

Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects

Influenza

Finland, United States, Poland
Novartis
Novartis Vaccines

Completed

Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents

Influenza

United States, Croatia, Finland, Hungary, Italy, Lithuania, Romania
Novartis Vaccines

Completed

Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60)

Influenza

Lithuania
Ology Bioservices

Completed

Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older

Influenza

United States
Ology Bioservices

Completed

Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)

Influenza

Austria, Germany, Poland
Novartis Vaccines

Completed

Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly

Influenza

Poland
Seqirus
Novartis Vaccines

Completed

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Influenza

United States, Germany
Changchun BCHT Biotechnology Co.
He Bei province Center for Disease control and prevention

Not yet recruiting

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Influenza Prevention

China
Liaoning Chengda Biotechnology CO., LTD

Recruiting

Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

Japanese Encephalitis | Measles | Rubella | Mumps

China
Brigham and Women's Hospital
National Institutes of Health (NIH)

Not yet recruiting

Multi-level School-based Intervention to Improve HPV Vaccine Uptake and Completion in South Africa

HPV

South Africa
Mayo Clinic

Enrolling by invitation

PAIN (Pain AI iNtervention) Platform for Patients at Home

Pain

United States
Hellenic Institute for the Study of Sepsis

Completed

Bacillus Calmette-guérin Vaccination to Prevent COVID-19 (ACTIVATEII)

Virus Diseases | COVID-19 | Chronic Obstructive Pulmonary Disease | Coronary Heart Disease | Corona Virus Infection

Greece
National Liver Institute, Egypt

Unknown

Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection (CENV3)

Vaccine Overdose of Undetermined Intent

Egypt
DynPort Vaccine Company LLC, A GDIT Company

Completed

Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers

Healthy Volunteers

United States
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Suspended

A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

Tuberculosis

China
Centers for Disease Control and Prevention

Completed

Study of Intradermal Administration of PCEC Rabies Vaccine (Rabies-ID)

Rabies Prevention | Rabies Exposure

United States
Ology Bioservices

Completed

Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups

Influenza

Austria, Belgium, Finland, Germany, Latvia, Lithuania, Netherlands
China National Biotec Group Company Limited
Peking University; Shaanxi Provincial Center for Disease Control and Prevention and other collaborators

Unknown

Evaluation of the Safety and Immunogenicity of Hepatitis A Vaccine

Vaccination

China
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Withdrawn

Safety and Immunogenicity of Q Fever Vaccine

Q Fever

United States
Ology Bioservices

Completed

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Influenza | Avian Influenza

Austria, Finland
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Recruiting

A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)

Safety and Efficacy | Rabies Vaccine Adverse Reaction

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Sponsor GmbH

Completed

A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)

Rabies Vaccine Adverse Reaction

China
Institute of Medical Biology, Chinese Academy of...
Jiangsu Province Centers for Disease Control and Prevention

Completed

The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines (HAV)

Hepatitis A

China
The Christie NHS Foundation Trust
Manchester University NHS Foundation Trust; Aptus Clinical Ltd.; Zenzium Ltd.

Completed

COntinuous Signs Monitoring In Covid-19 Patients (COSMIC-19)

COVID-19

United Kingdom
Novartis
Novartis Vaccines

Completed

Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup

Influenza

Poland
UMN Pharma Inc.

Completed

Study of ASP7374, Cell-culture-derived Influenza Vaccine

Influenza | Vaccine

Japan
UMN Pharma Inc.

Completed

Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine

Influenza

Japan
Seqirus

Completed

Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

Influenza, Human

United States
Ottawa Hospital Research Institute

Recruiting

NeuroCognitive Communicator: Safety Study (NCC-1701)

Tetraplegia | Motor Neuron Disease, Amyotrophic Lateral Sclerosis

Canada
University of Massachusetts, Worcester
National Library of Medicine (NLM)

Completed

Views on COVID-19 and Vaccination

Covid19

United States
Takeda

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination

Measles/Rubella

Japan
Takeda

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination

Measles/Rubella
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

Tuberculosis

China
Ology Bioservices

Completed

Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Influenza

Germany, Austria
Mayo Clinic
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Breast Cancer

United States
Ology Bioservices

Completed

A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents

Influenza | Pandemic Influenza

Austria, Germany
Indiana University
National Center for Advancing Translational Sciences (NCATS)

Recruiting

Mhealth Supported Bundle to Improve Vaccination Completion

Vaccination

Nigeria

3

Subscribe